Mobile

Interest of Topical Spironolactone's Administration to Prevent Corticoid-induced Epidermal Atrophy

Mise à jour : Il y a 4 ans
Référence : NCT01407471

Femme et Homme

  • | Pays :
  • France
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The purpose of this study is to determine whether spironolactone could significantly reduce cutaneous atrophy due to corticosteroids.

Critère d'inclusion

  • Cutaneous Atrophy Due to Corticosteroids

Liens